{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:56:40Z","timestamp":1790891800643,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"DOI":"10.1007\/s11095-026-04213-1","type":"journal-article","created":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:11:56Z","timestamp":1790889116000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fab-Level LC\u2013MS Assessment of Chain Pairing in Asymmetric Bispecific Antibodies Enabled by IdeS Digestion and Selective Hinge Reduction"],"prefix":"10.1007","author":[{"given":"Biao","family":"Shen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tri","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,1]]},"reference":[{"key":"4213_CR1","doi-asserted-by":"publisher","first-page":"309","DOI":"10.4161\/mabs.2.3.11791","volume":"2","author":"D Chelius","year":"2010","unstructured":"Chelius D, Ruf P, Gruber P, Ploscher M, Liedtke R, Gansberger E, et al. Structural and functional characterization of the trifunctional antibody catumaxomab. MAbs. 2010;2:309\u201319. https:\/\/doi.org\/10.4161\/mabs.2.3.11791.","journal-title":"MAbs"},{"key":"4213_CR2","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1093\/protein\/9.7.617","volume":"9","author":"JB Ridgway","year":"1996","unstructured":"Ridgway JB, Presta LG, Carter P. \u201cKnobs-into-holes\u201d engineering of antibody CH3 domains for heavy chain heterodimerization. Protein Eng. 1996;9:617\u201321. https:\/\/doi.org\/10.1093\/protein\/9.7.617.","journal-title":"Protein Eng"},{"key":"4213_CR3","doi-asserted-by":"publisher","first-page":"872","DOI":"10.4161\/mabs.26307","volume":"5","author":"W Shatz","year":"2013","unstructured":"Shatz W, Chung S, Li B, Marshall B, Tejada M, Phung W, et al. Knobs-into-holes antibody production in mammalian cell lines reveals that asymmetric afucosylation is sufficient for full antibody-dependent cellular cytotoxicity. MAbs. 2013;5:872\u201381. https:\/\/doi.org\/10.4161\/mabs.26307.","journal-title":"MAbs"},{"key":"4213_CR4","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.ccr.2011.09.003","volume":"20","author":"G Schaefer","year":"2011","unstructured":"Schaefer G, Haber L, Crocker LM, Shia S, Shao L, Dowbenko D, et al. A two-in-one antibody against HER3 and EGFR has superior inhibitory activity compared with monospecific antibodies. Cancer Cell. 2011;20:472\u201386. https:\/\/doi.org\/10.1016\/j.ccr.2011.09.003.","journal-title":"Cancer Cell"},{"key":"4213_CR5","doi-asserted-by":"publisher","first-page":"11187","DOI":"10.1073\/pnas.1019002108","volume":"108","author":"W Schaefer","year":"2011","unstructured":"Schaefer W, Regula JT, Bahner M, Schanzer J, Croasdale R, Durr H, et al. Immunoglobulin domain crossover as a generic approach for the production of bispecific IgG antibodies. Proc Natl Acad Sci U S A. 2011;108:11187\u201392. https:\/\/doi.org\/10.1073\/pnas.1019002108.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4213_CR6","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1016\/j.xphs.2021.04.010","volume":"110","author":"M Cao","year":"2021","unstructured":"Cao M, Parthemore C, Jiao Y, Korman S, Aspelund M, Hunter A, et al. Characterization and Monitoring of a Novel Light-heavy-light Chain Mispair in a Therapeutic Bispecific Antibody. J Pharm Sci. 2021;110:2904\u201315. https:\/\/doi.org\/10.1016\/j.xphs.2021.04.010.","journal-title":"J Pharm Sci"},{"key":"4213_CR7","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1080\/19420862.2019.1618675","volume":"11","author":"AR Evans","year":"2019","unstructured":"Evans AR, Capaldi MT, Goparaju G, Colter D, Shi FF, Aubert S, et al. Using bispecific antibodies in forced degradation studies to analyze the structure-function relationships of symmetrically and asymmetrically modified antibodies. MAbs. 2019;11:1101\u201312. https:\/\/doi.org\/10.1080\/19420862.2019.1618675.","journal-title":"MAbs"},{"key":"4213_CR8","doi-asserted-by":"publisher","first-page":"6113","DOI":"10.1038\/ncomms7113","volume":"6","author":"N Fischer","year":"2015","unstructured":"Fischer N, Elson G, Magistrelli G, Dheilly E, Fouque N, Laurendon A, et al. Exploiting light chains for the scalable generation and platform purification of native human bispecific IgG. Nat Commun. 2015;6:6113. https:\/\/doi.org\/10.1038\/ncomms7113.","journal-title":"Nat Commun"},{"key":"4213_CR9","doi-asserted-by":"publisher","first-page":"2450","DOI":"10.1038\/nprot.2014.169","volume":"9","author":"AF Labrijn","year":"2014","unstructured":"Labrijn AF, Meesters JI, Priem P, de Jong RN, van den Bremer ET, van Kampen MD, et al. Controlled Fab-arm exchange for the generation of stable bispecific IgG1. Nat Protoc. 2014;9:2450\u201363. https:\/\/doi.org\/10.1038\/nprot.2014.169.","journal-title":"Nat Protoc"},{"key":"4213_CR10","doi-asserted-by":"publisher","first-page":"1226","DOI":"10.1080\/19420862.2018.1511198","volume":"10","author":"C Wang","year":"2018","unstructured":"Wang C, Vemulapalli B, Cao M, Gadre D, Wang J, Hunter A, et al. A systematic approach for analysis and characterization of mispairing in bispecific antibodies with asymmetric architecture. MAbs. 2018;10:1226\u201335. https:\/\/doi.org\/10.1080\/19420862.2018.1511198.","journal-title":"MAbs"},{"key":"4213_CR11","doi-asserted-by":"publisher","first-page":"962","DOI":"10.4161\/mabs.26233","volume":"5","author":"MJ Gramer","year":"2013","unstructured":"Gramer MJ, van den Bremer ET, van Kampen MD, Kundu A, Kopfmann P, Etter E, et al. Production of stable bispecific IgG1 by controlled Fab-arm exchange: scalability from bench to large-scale manufacturing by application of standard approaches. MAbs. 2013;5:962\u201373. https:\/\/doi.org\/10.4161\/mabs.26233.","journal-title":"MAbs"},{"key":"4213_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14071381","author":"N Mohan","year":"2022","unstructured":"Mohan N, Agrawal A, Shen Y, Winarski KL, Endo Y, Dokmanovic M, et al. Comparative characterization of different molecular formats of bispecific antibodies targeting EGFR and PD-L1. Pharmaceutics. 2022. https:\/\/doi.org\/10.3390\/pharmaceutics14071381.","journal-title":"Pharmaceutics"},{"key":"4213_CR13","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-97393-2","volume":"11","author":"C Zhao","year":"2021","unstructured":"Zhao C, Zhang W, Gong G, Xie L, Wang MW, Hu Y. A new approach to produce IgG(4)-like bispecific antibodies. Sci Rep. 2021;11:18630. https:\/\/doi.org\/10.1038\/s41598-021-97393-2.","journal-title":"Sci Rep"},{"key":"4213_CR14","doi-asserted-by":"publisher","first-page":"12122","DOI":"10.1021\/acs.analchem.6b02866","volume":"88","author":"L Schachner","year":"2016","unstructured":"Schachner L, Han G, Dillon M, Zhou J, McCarty L, Ellerman D, et al. Characterization of chain pairing variants of bispecific IgG expressed in a single host cell by high-resolution native and denaturing mass spectrometry. Anal Chem. 2016;88:12122\u20137. https:\/\/doi.org\/10.1021\/acs.analchem.6b02866.","journal-title":"Anal Chem"},{"key":"4213_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1080\/19420862.2016.1232217","volume":"8","author":"Y Yin","year":"2016","unstructured":"Yin Y, Han G, Zhou J, Dillon M, McCarty L, Gavino L, et al. Precise quantification of mixtures of bispecific IgG produced in single host cells by liquid chromatography-Orbitrap high-resolution mass spectrometry. MAbs. 2016;8:1467\u201376. https:\/\/doi.org\/10.1080\/19420862.2016.1232217.","journal-title":"MAbs"},{"key":"4213_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/bioengineering9050209","author":"M Collins","year":"2022","unstructured":"Collins M, Khalili H. Soluble papain to digest monoclonal antibodies; time and cost-effective method to obtain Fab fragment. Bioengineering. 2022. https:\/\/doi.org\/10.3390\/bioengineering9050209.","journal-title":"Bioengineering"},{"key":"4213_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.ab.2006.05.037","volume":"355","author":"HS Gadgil","year":"2006","unstructured":"Gadgil HS, Bondarenko PV, Pipes GD, Dillon TM, Banks D, Abel J, et al. Identification of cysteinylation of a free cysteine in the Fab region of a recombinant monoclonal IgG1 antibody using Lys-C limited proteolysis coupled with LC\/MS analysis. Anal Biochem. 2006;355:165\u201374. https:\/\/doi.org\/10.1016\/j.ab.2006.05.037.","journal-title":"Anal Biochem"},{"key":"4213_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.jim.2020.112933","volume":"489","author":"H Khalili","year":"2021","unstructured":"Khalili H. Using different proteolytic enzymes to digest antibody and its impact on stability of antibody mimetics. J Immunol Methods. 2021;489:112933. https:\/\/doi.org\/10.1016\/j.jim.2020.112933.","journal-title":"J Immunol Methods"},{"key":"4213_CR19","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1080\/19420862.2017.1364325","volume":"9","author":"J Moelleken","year":"2017","unstructured":"Moelleken J, Endesfelder M, Gassner C, Lingke S, Tomaschek S, Tyshchuk O, et al. GingisKHAN protease cleavage allows a high-throughput antibody to Fab conversion enabling direct functional assessment during lead identification of human monoclonal and bispecific IgG1 antibodies. MAbs. 2017;9:1076\u201387. https:\/\/doi.org\/10.1080\/19420862.2017.1364325.","journal-title":"MAbs"},{"key":"4213_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.4161\/mabs.28762","volume":"6","author":"Y An","year":"2014","unstructured":"An Y, Zhang Y, Mueller HM, Shameem M, Chen X. A new tool for monoclonal antibody analysis: application of IdeS proteolysis in IgG domain-specific characterization. MAbs. 2014;6:879\u201393. https:\/\/doi.org\/10.4161\/mabs.28762.","journal-title":"MAbs"},{"key":"4213_CR21","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-019-2652-1","volume":"36","author":"S Majumder","year":"2019","unstructured":"Majumder S, Saati A, Philip S, Liu LL, Stephens E, Rouse JC, et al. Utility of high resolution NMR methods to probe the impact of chemical modifications on higher order structure of monoclonal antibodies in relation to antigen binding. Pharm Res. 2019;36:130. https:\/\/doi.org\/10.1007\/s11095-019-2652-1.","journal-title":"Pharm Res"},{"key":"4213_CR22","doi-asserted-by":"publisher","first-page":"270","DOI":"10.18869\/acadpub.ibj.21.4.270","volume":"21","author":"M Abdollahpour-Alitappeh","year":"2017","unstructured":"Abdollahpour-Alitappeh M, Lotfinia M, Razavi-Vakhshourpour S, Jahandideh S, Najminejad H, Sineh Sepehr K, et al. Evaluation of factors influencing antibody reduction for development of antibody drug conjugates. Iran Biomed J. 2017;21:270\u20134. https:\/\/doi.org\/10.18869\/acadpub.ibj.21.4.270.","journal-title":"Iran Biomed J"},{"key":"4213_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbrep.2015.04.004","volume":"2","author":"V Crivianu-Gaita","year":"2015","unstructured":"Crivianu-Gaita V, Romaschin A, Thompson M. High efficiency reduction capability for the formation of Fab\u05f3 antibody fragments from F(ab)(2) units. Biochem Biophys Rep. 2015;2:23\u20138. https:\/\/doi.org\/10.1016\/j.bbrep.2015.04.004.","journal-title":"Biochem Biophys Rep"},{"key":"4213_CR24","doi-asserted-by":"publisher","first-page":"2648","DOI":"10.1021\/jo00008a014","volume":"56","author":"A John","year":"1991","unstructured":"John A, Burns JCB, Moran J, Whitesides GM. Selective reduction of disulfides by tris(2-carboxyethyl)phosphine. J Organic Chem. 1991;56:2648\u201350.","journal-title":"J Organic Chem"},{"key":"4213_CR25","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.bbrc.2016.10.128","volume":"480","author":"TL Kirley","year":"2016","unstructured":"Kirley TL, Greis KD, Norman AB. Selective disulfide reduction for labeling and enhancement of Fab antibody fragments. Biochem Biophys Res Commun. 2016;480:752\u20137. https:\/\/doi.org\/10.1016\/j.bbrc.2016.10.128.","journal-title":"Biochem Biophys Res Commun"},{"key":"4213_CR26","doi-asserted-by":"publisher","first-page":"5145","DOI":"10.1073\/pnas.1220145110","volume":"110","author":"AF Labrijn","year":"2013","unstructured":"Labrijn AF, Meesters JI, de Goeij BE, van den Bremer ET, Neijssen J, van Kampen MD, et al. Efficient generation of stable bispecific IgG1 by controlled Fab-arm exchange. Proc Natl Acad Sci U S A. 2013;110:5145\u201350. https:\/\/doi.org\/10.1073\/pnas.1220145110.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4213_CR27","doi-asserted-by":"publisher","first-page":"30445","DOI":"10.1074\/jbc.M001672200","volume":"275","author":"JB Stimmel","year":"2000","unstructured":"Stimmel JB, Merrill BM, Kuyper LF, Moxham CP, Hutchins JT, Fling ME, et al. Site-specific conjugation on serine right-arrow cysteine variant monoclonal antibodies. J Biol Chem. 2000;275:30445\u201350. https:\/\/doi.org\/10.1074\/jbc.M001672200.","journal-title":"J Biol Chem"},{"key":"4213_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1007\/s00216-024-05707-w","volume":"417","author":"Y Yang","year":"2025","unstructured":"Yang Y, Patel JM, Yang RS, Ma F, Niu X, Zhang Y, et al. Determination of the decapping efficiency of THIOMAB antibodies with the engineered cysteine in the Fc region for making antibody-drug conjugates by specific hinge fragmentation-liquid chromatography. Anal Bioanal Chem. 2025;417:847\u201359. https:\/\/doi.org\/10.1007\/s00216-024-05707-w.","journal-title":"Anal Bioanal Chem"},{"key":"4213_CR29","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1111\/j.1432-1033.1979.tb19731.x","volume":"101","author":"S Yoshitake","year":"1979","unstructured":"Yoshitake S, Yamada Y, Ishikawa E, Masseyeff R. Conjugation of glucose oxidase from Aspergillus niger and rabbit antibodies using N-hydroxysuccinimide ester of N-(4-carboxycyclohexylmethyl)-maleimide. Eur J Biochem. 1979;101:395\u20139. https:\/\/doi.org\/10.1111\/j.1432-1033.1979.tb19731.x.","journal-title":"Eur J Biochem"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11095-026-04213-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-026-04213-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T21:11:57Z","timestamp":1790889117000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11095-026-04213-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,1]]},"references-count":29,"alternative-id":["4213"],"URL":"https:\/\/doi.org\/10.1007\/s11095-026-04213-1","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,1]]},"assertion":[{"value":"27 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 October 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","label":"Competing interest","group":{"name":"EthicsHeading","label":"Declarations"}}]}}